This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr McCormick and colleagues¹ found that residents' attitudes and behavior were influenced by the amount of their exposure to pharmaceutical company representatives. As a resident in a program that has a long commitment to independence from pharmaceutical representatives, I support the authors' conclusions.

When patients ask me about the availability of complimentary samples at our practice, I am proud to tell them of our policy barring pharmaceutical representatives. We in the medical profession have primarily our integrity to offer patients; without our patients' trust how can we expect them to follow our advice for treatment or even to forgive us our human mistakes? When I explain to my patients that my recommendations to them are based on studies published with disclosure in journals and not on my gratitude for a "drug lunch," they rarely complain about our lack of free medication.

As I complete my residency and . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Effect of Restricting Contact Between Pharmaceutical Company Representatives and Internal Medicine Residents on Posttraining Attitudes and Behavior
Brendan B. McCormick, George Tomlinson, Patrick Brill-Edwards, and Allan S. Detsky
JAMA. 2001;286(16):1994-1999.
ABSTRACT | FULL TEXT